Benign Prostatic Hyperplasia Clinical Trials 2024 FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight Boehringer Ingelheim, Merck Co. Inc., Allergan PLC - Barchart
086450 Stock | KRW 16,640 40.00 0.24% |
About 62% of DongKook Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in DongKook Pharmaceutical Co suggests that many traders are alarmed regarding DongKook Pharmaceutical's prospects. The current market sentiment, together with DongKook Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use DongKook Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
DongKook |
Benign Prostatic Hyperplasia Clinical Trials 2024 FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight Boehringer Ingelheim, Merck Co. Inc., Allergan PLC Barchart
Read at news.google.com
DongKook Pharmaceutical Fundamental Analysis
We analyze DongKook Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DongKook Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DongKook Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
DongKook Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DongKook Pharmaceutical stock to make a market-neutral strategy. Peer analysis of DongKook Pharmaceutical could also be used in its relative valuation, which is a method of valuing DongKook Pharmaceutical by comparing valuation metrics with similar companies.
Peers
DongKook Pharmaceutical Related Equities
000660 | SK Hynix | 2.62 | ||||
000270 | Kia Corp | 0.42 | ||||
005387 | Hyundai | 1.15 | ||||
034730 | SK Holdings | 1.34 | ||||
005385 | Hyundai | 1.94 | ||||
005380 | Hyundai | 2.13 | ||||
005490 | POSCO Holdings | 2.40 | ||||
005930 | Samsung Electronics | 2.52 | ||||
005935 | Samsung Electronics | 3.97 |
Complementary Tools for DongKook Stock analysis
When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |